A chemigenetic endogenous Ras activity biosensor for live-cell pharmacology

Ryan Weeks1,2, Daojia R Zhou1,3, Michelle S Frei1

  • 1Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.

Nature Chemical Biology
|August 19, 2026
PubMed

Insights

Researchers developed a new chemigenetic biosensor, HaloRasAR, to track Ras protein activity in real-time within cells. This tool enhances understanding of Ras signaling in cancer and drug development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Ras GTPases are key regulators of cell growth and proliferation.
  • Hyperactive Ras is implicated in various cancers, making it a significant therapeutic target.
  • Current biosensors lack the quantitative capacity to measure endogenous Ras activity effectively.

Purpose of the Study:

  • To develop a novel chemigenetic biosensor for detecting and tracking endogenous Ras activity.
  • To overcome the limitations of existing biosensors in quantitative measurements.
  • To visualize the spatiotemporal dynamics of Ras signaling in live cells.

Main Methods:

  • Introduction of a chemigenetic biosensor design utilizing a circularly permuted HaloTag labeled with JF635.
  • Development of the HaloTag-based Ras Activity Reporter (HaloRasAR).
  • Live-cell imaging to monitor Ras activity dynamics and inhibitor effects.

Main Results:

  • HaloRasAR successfully revealed spatiotemporal dynamics of Ras activity.
  • The biosensor tracked Ras activity downstream of growth factor and protein kinase C signaling.
  • Live-cell characterization identified subcellular-specific inhibition profiles for Ras inhibitors.

Conclusions:

  • HaloRasAR represents a significant advancement in spatiotemporal interrogation of Ras signaling.
  • The biosensor enables precise live-cell pharmacology studies.
  • This tool facilitates a deeper understanding of Ras function in normal and cancerous cells.